Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Translational Science of Rare Diseases is Scopus-indexed (Q3, CiteScore 0.5). It is covered by India's One Nation One Subscription scheme for reading access. Published by SAGE Publications Ltd.
Checked against the index lists dated .
ISSN 2214-6490Verify ISSN ↗2214-6512Verify ISSN ↗
Publisher: SAGE Publications Ltd
Cost to publish: About US$3,900 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (all) | 491 / 669 | 26th | Q3 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2022–present (also 2019–2020), best quartile Q3, CiteScore 0.5.
Translational Science of Rare Diseases is Q3 in Medicine (all) (rank 491 of 669), by CiteScore 2025.
Translational Science of Rare Diseases is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.5, quartile Q3, 26th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.152, quartile Q4, with an H-index of 3.
The publisher lists an article processing charge of about US$3,900 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Translational Science of Rare Diseases is published by SAGE Publications Ltd. Its print ISSN is 2214-6490 and its online ISSN is 2214-6512.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Translational Science of Rare Diseases has an h-index of 16 and a 2-year mean of 0.05 citations per paper (OpenAlex). Its Scopus CiteScore is 0.5, quartile Q3. On 2-year citations it ranks #524 of 646 Scopus journals in Medicine (all).
Translational Science of Rare Diseases published 8 papers in 2025; its busiest recent year was 2019 with 16. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 33 research articles (2021–2026), authors are most often from United States (41%), Iraq (9.1%) and Malaysia (6.1%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.